Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Encouraging Biomarker Data Lift UniQure’s Huntington’s Disease Hopes
Results Exceeded Expectations
Jun 24 2022
•
By
Andrew McConaghie
The safety and biomarker data are encouraging, but it will take until 2023 before any potential disease modifying data are available. • Source: UniQure
More from Business
More from Scrip